Vol 6, No 2 (2013)
Poglądy, stanowiska, zalecenia, standardy i opinie
Published online: 2013-06-01
Mycophenolate mofetil in therapy of nephrotic syndrome in children
Forum Nefrologiczne 2013;6(2):130-134.
Abstract
Mycophenolate mofetil (MMF) has been used inpediatric nephrotic syndrome for decade. Steroid dependentand frequently relapsing nephrotic syndrome is the major therapeutic target. As non-nephrotoxic, MMF is attractive is terms of long-term therapy and conversion from cyclosporine. Therapeutic drug monitoring seems to be reasonable and C0 should be maintained between 2 and 3 μg/ml.